Click here to learn about Academy events, publications and initiatives around COVID-19.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

Support The World's Smartest Network
×

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

DONATE
This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Drug Discovery for Remission of Chronic Kidney Disease

WEBINAR

Only

Drug Discovery for Remission of Chronic Kidney Disease

Friday, September 25, 2020, 10:30 AM - 5:20 PM EDT

7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

Biochemical Pharmacology Discussion Group

The New York Academy of Sciences

 

Thirty million Americans have chronic kidney disease (CKD) and over 600,000 are currently living with end stage kidney disease (ESKD), requiring dialysis or kidney transplantation to sustain their lives. However, the great majority of patients living with ESKD do not have access to kidney transplantation due to the scarcity of donor organs. Moreover, there have been few advances in effective treatments for patients living with kidney disease in the past fifty years.

This symposium will highlight the latest research on the physiological and genetic mechanisms underlying CKD, as well as novel imaging techniques and emerging biomarkers that promise improved detection and characterization of the disease. There will also be discussion of recent progress and remaining hurdles for novel ESKD treatment strategies, including kidney xenotranplantation.

Call for Abstracts

Abstract submissions are invited for a poster session and short talks. For complete submission instructions, please visit our online portal. The deadline for abstract submission is Friday, July 24, 2020.

Registration

Member
$30
Nonmember Academia, Faculty, etc.
$65
Nonmember Corporate, Other
$85
Nonmember Not for Profit
$65
Nonmember Student, Undergrad, Grad, Fellow
$45
Member Student, Post-Doc, Fellow
$15

Keynote Speaker

Jonathan Himmelfarb, MD
Jonathan Himmelfarb, MD

University of Washington

Speakers

Kevin Bennett, PhD
Kevin Bennett, PhD

Washington University in St. Louis

Xunrong Luo
Xunrong Luo, MD, PhD

Duke University School of Medicine

Benjamin Freedman
Benjamin Freedman, PhD

University of Washington

Monika Niewczas
Monika Niewczas, MD, PhD, MPH

Joslin Diabetes Center, Harvard Medical School

Ali Gharavi
Ali Gharavi, MD

Columbia University Vagelos College of Physicians and Surgeons

Karin Hehenberger, MD, PhD
Karin Hehenberger, MD, PhD

Lyfebulb

Katalin Susztak, MD, PhD
Katalin Susztak, MD, PhD

Perelman School of Medicine, University of Pennsylvania

Katherine Tuttle, MD
Katherine Tuttle, MD

Providence Health Care & University of Washington

Scientific Organizing Committee

Matthew D. Breyer, MD

Janssen Pharmaceuticals

Kishor Devalaraja-Narashimha, DVM, PhD

Regeneron Pharmaceuticals

Susan Quaggin, MD

Northwestern University

Michael Ross, MD

Albert Einstein College of Medicine

Joseph Vassalotti, MD

National Kidney Foundation

Sara Donnelly, PhD

New York Academy of Sciences

Sonya Dougal, PhD

New York Academy of Sciences

Friday

September 25, 2020

10:30 AM

Introduction and Welcome Remarks

10:40 AM

Keynote: Drug Discovery for Kidney Precision Medicine

Speaker

Jonathan Himmelfarb, MD
University of Washington

Session 1

11:25 AM

How Patients Can and Should Impact Innovation in Kidney Disease

Speaker

Karin M. Hehenberger, MD, PhD
LyfeBulb
11:55 AM

Break

12:05 PM

Inflammatory Proteomic Signature of Kidney Failure Risk - a Biomarker Path to Drug Development

Speaker

Monika Niewczas, PhD, MD, MPH
Joslin Diabetes Center, Harvard Medical School
12:35 PM

New Strategies for Diabetic Kidney Disease

Speaker

Katherine Tuttle, MD, PhD
Providence Health Care & University of Washington

Session 2: Data Blitz Talks

1:05 PM

2 short talks selected from submitted abstracts

1:35 PM

Break and Virtual Poster Session

Session 3

2:35 PM

Multi-omics Analysis of Diabetic Kidney Disease

Speaker

Katalin Susztak, MD, PhD
University of Pennsylvania
3:05 PM

In Vivo Imaging Tools to Map the Kidney at the Single Nephron Level

Speaker

Kevin Bennett, PhD
Washington University in St. Louis
3:35 PM

Break

3:45 PM

Talk title to be confirmed

Speaker

Xunrong Luo, MD, PhD
Duke University School of Medicine
4:15 PM

Human Organoid Models of Kidney Disease

Speaker

Benjamin Freedman, PhD
University of Washington
4:45 PM

Genomic Medicine for Kidney Diseases

Speaker

Ali Gharavi, MD
Columbia University Vagelos College of Physicians of Surgeons
5:15 PM

Closing Remarks

5:20 PM

Adjourn